Observational Studies Requested by European Health Authorities: Governmental Interference or an Enhancement of Everyday Urological Practice? The Hexvix® Observational Patients Evaluation Study as an Example of What to Expect.
Fiche publication
Date publication
août 2017
Journal
Urologia internationalis
Auteurs
Membres identifiés du Cancéropôle Est :
Pr JACQMIN Didier
Tous les auteurs :
Jacqmin D, Jichlinski P, Molinier L, de la Taille A, Irani J, Malavaud B
Lien Pubmed
Résumé
The Hexvix® Observational Patients Evaluation (HOPE) study was designed to determine the extent of distribution of the use of hexaminolevulinate in the diagnosis of non-muscle invasive bladder cancer (NMIBC) and assess patient and treatment characteristics associated with different endoscopic modalities and to address the French authorities' request for information on routine practices for NMIBC diagnosis and surveillance.
Mots clés
European Union regulation, Hexaminolevulinate, Non-muscle invasive bladder cancer, Observational studies
Référence
Urol. Int.. 2017 Aug;: